share_log

Organto Provides Update on Private Placement Financing

Organto Provides Update on Private Placement Financing

Organto 提供私募融資的最新信息
Accesswire ·  2023/12/05 17:10

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

不用於分發給美國新聞通訊社或在美國傳播

TORONTO, ON and BREDA, THE NETHERLANDS / ACCESSWIRE / December 5, 2023 / Organto Foods Inc. (TSXV:OGO)(OTCQB:OGOFF)(FSE:OGF) ("Organto" or "the Company"), an integrated provider of branded, private label and bulk distributed organic and non-GMO fruit and vegetable products today provided an update on its previously announced common share private placement financing (the "Private Placement") (see November 14, 2023 news release).

安大略省多倫多和荷蘭佈雷達/ACCESSWIRE/2023年12月5日/品牌、自有品牌和批量分銷有機和非轉基因水果和蔬菜產品的綜合提供商Organto Foods Inc.(多倫多證券交易所股票代碼:OGOFF)(“Organto” 或 “公司”)今天公佈了其先前宣佈的普通股私募融資(“私募配售”)的最新情況”)(參見 2023 年 11 月 14 日新聞稿)。

To date the Company has raised a total of CDN $758,000 through the sale of 2,296,970 common shares at a price of CDN $0.33 per share. Certain directors, officers and insiders of the Company directly, through entities controlled by them, or through entities for which they exercise control or direction over investment decisions, have purchased an aggregate of 1,751,515 common shares for gross proceeds of CDN $578,000. Under Canadian securities laws, the securities are subject to a hold period expiring on April 7th, 2024. No finder's fees are payable on the shares purchased thus far.

迄今爲止,該公司通過以每股0.33加元的價格出售2,296,970股普通股,共籌集了75.8萬加元。公司的某些董事、高級管理人員和內部人士通過其控制的實體或通過他們對投資決策行使控制權或指導權的實體,共購買了1,751,515股普通股,總收益爲57.8萬加元。根據加拿大證券法,這些證券的持有期將於4月7日到期第四,2024。迄今爲止購買的股票無需支付任何發現費。

The Company also has secured further commitments for CDN $575,000 to be closed in further tranches, with the next tranche expected to close on December 11th or as soon as practically possible.

該公司還獲得了進一步的57.5萬加元的承諾,將在下一批中完成,下一批預計將於12月11日完成第四 或者儘快。

All tranches of the Private Placement remain subject to acceptance by the TSX Venture Exchange.

私募的所有部分仍需獲得多倫多證券交易所風險交易所的接受。

Organto plans to use the proceeds from the Private Placement for funding growth initiatives and for general working capital purposes.

Organto計劃將私募的收益用於資助增長計劃和一般營運資金用途。

The securities offered have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold absent registration or compliance with an applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws.

所發行證券未根據經修訂的1933年《美國證券法》(“美國證券法”)或任何州證券法進行註冊,未經註冊或未遵守《美國證券法》和適用州證券法的註冊要求的適用豁免,不得發行或出售。

ON BEHALF OF THE COMPANY,

代表公司,

Steve Bromley
Chair and Co-Chief Executive Officer

史蒂夫·布羅姆利
主席兼聯席首席執行官

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

For more information contact:

欲了解更多信息,請聯繫:

Investor Relations
info@organto.com
John Rathwell, Senior Vice President, Corporate Development and Investor Relations
647 629 0018

投資者關係
info@organto.com
John Rathwell,企業發展和投資者關係高級副總裁
647 629 0018

ABOUT ORGANTO

關於 ORGANTO

Organto is an integrated provider of branded, private label, and distributed organic and non-GMO fruit and vegetable products using a strategic asset-light business model to serve a growing socially responsible and health-conscious consumer around the globe. Organto's business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people, and its shareholders.

Organto是品牌、自有品牌和分銷的有機和非轉基因水果和蔬菜產品的綜合提供商,使用戰略性輕資產商業模式,爲全球日益增長的具有社會責任感和健康意識的消費者提供服務。Organto的商業模式植根於其對以環境責任爲重點的可持續商業實踐的承諾以及對其運營所在社區、員工和股東的承諾。

FORWARD LOOKING STATEMENTS

前瞻性陳述

This news release may include certain forward-looking information and statements, as defined by law including without limitation Canadian securities laws and the "safe harbor" provisions of the US Private Securities Litigation Reform Act of 1995 ("forward-looking statements"). In particular, and without limitation, this news release contains forward-looking statements respecting Organto's business model and markets; Organto's belief that it has secured further commitments of CDN$575,000 for the next tranche of the Private Placement; Organto's belief that it will close the next tranche of the Private Placement on December 11, 2023 or as soon as practically possible; Organto's belief that it will use the proceeds from the Private Placement to fund growth initiatives and for general working capital purposes; management's beliefs, assumptions and expectations; and general business and economic conditions. Forward-looking statements are based on a number of assumptions that may prove to be incorrect, including without limitation assumptions about the following: the ability and time frame within which Organto's business model will be implemented and product supply will be increased; cost increases; dependence on suppliers, partners, and contractual counter-parties; changes in the business or prospects of Organto; unforeseen circumstances; risks associated with the organic produce business generally, including inclement weather, unfavorable growing conditions, low crop yields, variations in crop quality, spoilage, import and export laws, and similar risks; transportation costs and risks; general business and economic conditions; and ongoing relations with distributors, customers, employees, suppliers, consultants, contractors, and partners. The foregoing list is not exhaustive and Organto undertakes no obligation to update any of the foregoing except as required by law.

本新聞稿可能包含某些前瞻性信息和陳述,這些信息和陳述由法律定義,包括但不限於加拿大證券法和1995年《美國私人證券訴訟改革法》的 “安全港” 條款(“前瞻性陳述”)。特別是,但不限於,本新聞稿包含有關Organto商業模式和市場的前瞻性陳述;Organto認爲已爲下一批私募配售獲得進一步的57.5萬加元的承諾;Organto認爲將在2023年12月11日或儘快完成下一批私募配售;Organto認爲它將使用私募的收益爲增長計劃提供資金,以及用於一般營運資金用途;管理層的信念,假設和期望; 以及一般的商業和經濟狀況.前瞻性陳述基於許多可能被證明是不正確的假設,包括但不限於對以下方面的假設:實施Organto商業模式和增加產品供應的能力和時限;成本增加;對供應商、合作伙伴和合同對手的依賴;Organto業務或前景的變化;不可預見的情況;與有機農產品業務相關的總體風險,包括惡劣天氣、不利的生長條件、低谷作物產量、作物質量的變化、腐壞、進出口法律和類似風險;運輸成本和風險;一般業務和經濟狀況;以及與分銷商、客戶、員工、供應商、顧問、承包商和合作夥伴的持續關係。上述清單並不詳盡,除非法律要求,否則Organto沒有義務更新上述任何內容。

SOURCE: Organto Foods Inc.

來源:Organto Foods Inc.


View source version on accesswire.com:
在 accesswire.com 上查看源代碼版本:

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論